Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,709 | 98 | 96.7% |
| Honoraria | $125.00 | 1 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $739.93 | 18 | $0 (2024) |
| Genentech USA, Inc. | $645.58 | 14 | $0 (2023) |
| Alcon Vision LLC | $487.57 | 17 | $0 (2024) |
| ABBVIE INC. | $352.21 | 8 | $0 (2024) |
| Allergan, Inc. | $319.21 | 7 | $0 (2021) |
| Horizon Therapeutics plc | $216.37 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $164.02 | 3 | $0 (2024) |
| Alimera Sciences, Inc. | $158.20 | 6 | $0 (2024) |
| Welch Allyn | $125.00 | 1 | $0 (2018) |
| Oyster Point Pharma, Inc. | $113.53 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $620.20 | 21 | Alcon Vision LLC ($219.75) |
| 2023 | $689.13 | 23 | Regeneron Healthcare Solutions, Inc. ($226.62) |
| 2022 | $847.85 | 19 | Genentech USA, Inc. ($414.14) |
| 2021 | $472.51 | 16 | Alcon Vision LLC ($134.15) |
| 2020 | $109.23 | 2 | Regeneron Healthcare Solutions, Inc. ($94.76) |
| 2019 | $154.44 | 4 | Novartis Pharmaceuticals Corporation ($88.96) |
| 2018 | $461.35 | 7 | AbbVie, Inc. ($150.70) |
| 2017 | $479.28 | 7 | Allergan Inc. ($186.80) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | PAVBLU (Biological) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Ophthalmology | ||||||
| 10/28/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $14.55 | General |
| 06/25/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: Ophthalmology | ||||||
| 06/13/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Ophthalmology | ||||||
| 06/12/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $115.31 | General |
| Category: Ophthalmology | ||||||
| 06/04/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: EYE CARE | ||||||
| 05/30/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Ophthalmology | ||||||
| 05/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/25/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 04/25/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Ophthalmology | ||||||
| 04/24/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Ophthalmology | ||||||
| 03/14/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Ophthalmology | ||||||
| 03/08/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Ophthalmology | ||||||
| 03/07/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $112.01 | General |
| Category: Ophthalmology | ||||||
| 02/26/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 02/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/29/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/27/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/27/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $106.89 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/12/2023 | Alimera Sciences, Inc. | YUTIQ (Drug) | Food and Beverage | Cash or cash equivalent | $17.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/14/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,650 | 54,238 | $4.9M | $2.3M |
| 2022 | 20 | 3,403 | 14,006 | $3.9M | $1.7M |
| 2021 | 16 | 2,860 | 6,927 | $3.3M | $1.5M |
| 2020 | 18 | 2,347 | 5,613 | $2.3M | $949,434 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 186 | 47,526 | $2.1M | $1.4M | 66.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 99 | 649 | $687,252 | $449,012 | 65.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 326 | 1,233 | $845,400 | $112,236 | 13.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 155 | 240 | $480,000 | $104,958 | 21.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 511 | 553 | $103,411 | $47,874 | 46.3% |
| 92134 | Imaging of retina | Office | 2023 | 627 | 1,577 | $236,550 | $47,247 | 20.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 396 | 717 | $90,701 | $46,863 | 51.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 440 | 440 | $110,374 | $46,839 | 42.4% |
| 92250 | Photography of the retina | Office | 2023 | 524 | 633 | $88,620 | $17,912 | 20.2% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 14 | 17 | $40,800 | $10,210 | 25.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 34 | 35 | $35,814 | $10,073 | 28.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 55 | 165 | $16,500 | $9,019 | 54.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 173 | 246 | $44,280 | $7,446 | 16.8% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 19 | 19 | $29,925 | $3,728 | 12.5% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 12 | 12 | $28,800 | $3,267 | 11.3% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 23 | 23 | $3,163 | $1,450 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 21 | $2,625 | $1,113 | 42.4% |
| 67515 | Injection of drug or substance into membrane covering eyeball | Office | 2023 | 15 | 21 | $5,590 | $761.24 | 13.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 11 | 11 | $1,573 | $463.95 | 29.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 100 | $375.00 | $73.73 | 19.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 159 | 1,198 | $1.3M | $861,164 | 67.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 67 | 6,306 | $278,568 | $188,180 | 67.6% |
| J3590 | Unclassified biologics | Office | 2022 | 32 | 70 | $185,519 | $124,072 | 66.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 19 | 465 | $199,950 | $103,845 | 51.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 286 | 1,145 | $788,400 | $103,742 | 13.2% |
About Dr. Maxwell Elia, MD
Dr. Maxwell Elia, MD is a Retina Specialist healthcare provider based in Manchester, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1902192669.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maxwell Elia, MD has received a total of $3,834 in payments from pharmaceutical and medical device companies, with $620.20 received in 2024. These payments were reported across 99 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,709).
As a Medicare-enrolled provider, Elia has provided services to 12,260 Medicare beneficiaries, totaling 80,784 services with total Medicare billing of $6.4M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Manchester, NH
- Active Since 06/21/2011
- Last Updated 11/04/2025
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1902192669
Products in Payments
- EYLEA (Biological) $516.18
- Lucentis (Biological) $345.55
- Clareon (Device) $313.27
- YUTIQ (Drug) $227.93
- Humira (Biological) $224.48
- EYLEA HD (Biological) $223.75
- VABYSMO (Drug) $205.65
- TEPEZZA (Drug) $203.01
- RESTASIS (Drug) $186.80
- OZURDEX (Drug) $172.41
- Izervay (Drug) $164.02
- RetinaVue Network (Device) $125.00
- AcrySof IQ PanOptix (Device) $123.83
- TYRVAYA (Drug) $113.53
- enVista MX60 IOL (Device) $84.52
- EYLEA AFLIBERCEPT INJECTION (Biological) $68.40
- Monaco (Device) $53.13
- Syfovre (Drug) $44.05
- Actemra (Biological) $33.75
- PAVBLU (Biological) $26.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.